News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
169,803 Results
Type
Article (7085)
Company Profile (50)
Press Release (162668)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (53612)
Career Advice (210)
Deals (9047)
Drug Delivery (8)
Drug Development (24551)
Employer Resources (22)
FDA (4210)
Job Trends (4184)
News (89365)
Policy (7310)
Tag
Academia (497)
Accelerated approval (2)
Adcomms (2)
Allergies (43)
Alliances (7577)
ALS (51)
Alzheimer's disease (553)
Antibody-drug conjugate (ADC) (54)
Approvals (4325)
Artificial intelligence (135)
Autoimmune disease (12)
Automation (10)
Bankruptcy (48)
Best Places to Work (3962)
BIOSECURE Act (4)
Biosimilars (46)
Biotechnology (32)
Bladder cancer (58)
Brain cancer (15)
Breast cancer (200)
Cancer (1424)
Cardiovascular disease (95)
Career advice (187)
Career pathing (9)
CAR-T (53)
CDC (3)
Cell therapy (162)
Cervical cancer (13)
Clinical research (21887)
Collaboration (418)
Company closure (1)
Compensation (275)
Complete response letters (5)
COVID-19 (915)
CRISPR (23)
C-suite (109)
Cystic fibrosis (48)
Data (1590)
Depression (14)
Diabetes (142)
Diagnostics (1802)
Digital health (15)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (49)
Drug pricing (11)
Drug shortages (4)
Duchenne muscular dystrophy (62)
Earnings (39589)
Editorial (6)
Employer branding (2)
Employer resources (22)
Events (27326)
Executive appointments (372)
FDA (5042)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (395)
Gene editing (42)
Generative AI (4)
Gene therapy (134)
GLP-1 (267)
Government (1283)
Grass and pollen (2)
Guidances (146)
Healthcare (5700)
HIV (28)
Huntington's disease (14)
IgA nephropathy (24)
Immunology and inflammation (43)
Immuno-oncology (1)
Indications (22)
Infectious disease (983)
Inflammatory bowel disease (40)
Influenza (26)
Intellectual property (34)
Interviews (40)
IPO (5754)
IRA (3)
Job creations (535)
Job search strategy (151)
Kidney cancer (8)
Labor market (15)
Layoffs (95)
Leadership (1)
Legal (1189)
Liver cancer (29)
Longevity (5)
Lung cancer (209)
Lymphoma (121)
Machine learning (5)
Management (7)
Manufacturing (127)
MASH (55)
Medical device (3829)
Medtech (3829)
Mergers & acquisitions (3656)
Metabolic disorders (341)
Multiple sclerosis (51)
NASH (10)
Neurodegenerative disease (40)
Neuropsychiatric disorders (4)
Neuroscience (810)
NextGen: Class of 2025 (1262)
Non-profit (1056)
Now hiring (2)
Obesity (148)
Opinion (21)
Ovarian cancer (36)
Pain (35)
Pancreatic cancer (49)
Parkinson's disease (72)
Partnered (4)
Patents (83)
Patient recruitment (65)
Peanut (23)
People (7922)
Pharmaceutical (16)
Pharmacy benefit managers (2)
Phase I (5697)
Phase II (9345)
Phase III (8616)
Pipeline (1037)
Policy (15)
Postmarket research (862)
Preclinical (1817)
Press Release (16)
Prostate cancer (84)
Psychedelics (1)
Radiopharmaceuticals (65)
Rare diseases (159)
Real estate (872)
Recruiting (13)
Regulatory (5703)
Reports (17)
Research institute (497)
Resumes & cover letters (18)
Rett syndrome (6)
RNA editing (1)
RSV (26)
Schizophrenia (29)
Series A (65)
Series B (42)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (58)
Sponsored (8)
Startups (478)
Stomach cancer (2)
Supply chain (31)
Tariffs (8)
The Weekly (1)
Vaccines (293)
Venture capital (7)
Weight loss (83)
Women's health (19)
Worklife (5)
Date
Today (30)
Last 7 days (163)
Last 30 days (896)
Last 365 days (14823)
2025 (8474)
2024 (12053)
2023 (10779)
2022 (22611)
2021 (20163)
2020 (12692)
2019 (10292)
2018 (7758)
2017 (7126)
2016 (5759)
2015 (7551)
2014 (5326)
2013 (3782)
2012 (4524)
2011 (4663)
2010 (4260)
Location
Africa (128)
Alabama (17)
Alaska (2)
Arizona (44)
Arkansas (4)
Asia (10119)
Australia (1383)
California (3482)
Canada (937)
China (233)
Colorado (152)
Connecticut (202)
Delaware (132)
Europe (23613)
Florida (383)
Georgia (91)
Hawaii (2)
Idaho (13)
Illinois (291)
India (11)
Indiana (154)
Iowa (7)
Japan (148)
Kansas (17)
Kentucky (7)
Louisiana (8)
Maine (27)
Maryland (468)
Massachusetts (2589)
Michigan (75)
Minnesota (216)
Mississippi (1)
Missouri (37)
Montana (6)
Nebraska (2)
Nevada (37)
New Hampshire (20)
New Jersey (1035)
New Mexico (6)
New York (917)
North Carolina (361)
North Dakota (1)
Northern California (1512)
Ohio (81)
Oklahoma (4)
Oregon (12)
Pennsylvania (593)
Puerto Rico (7)
Rhode Island (10)
South America (186)
South Carolina (8)
Southern California (1264)
Tennessee (58)
Texas (493)
United States (12246)
Utah (72)
Virginia (96)
Washington D.C. (26)
Washington State (306)
West Virginia (2)
Wisconsin (58)
169,803 Results for "24".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM
June 23, 2025
·
10 min read
Press Releases
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
June 26, 2025
·
1 min read
Press Releases
Alligator to Present 24-Month OPTIMIZE-1 Data at ESMO GI 2025
July 1, 2025
·
2 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - June 24, 2025
June 25, 2025
·
1 min read
Press Releases
Oncology Drugs Market Size to Reach USD 366.24 Billion By 2034
June 18, 2025
·
1 min read
Press Releases
Annovis to Host Webinar and Live Q&A on June 24, 2025
June 6, 2025
·
2 min read
Press Releases
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
June 23, 2025
·
8 min read
Press Releases
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
June 18, 2025
·
5 min read
Press Releases
Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26
June 26, 2025
·
5 min read
Press Releases
Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
June 18, 2025
·
6 min read
1 of 16,981
Next
